Oracle Health Sciences InForm GTM 6.0 With Oracle Health Sciences Central Designer 2.0 Accelerates Clinical Studies

New Features and Support for Mobile Devices Streamline Data Collection and Review to Increase Productivity and Improve Site Experience

(firmenpresse) - REDWOOD SHORES, CA -- (Marketwired) -- 06/24/13 -- Oracle (NASDAQ: ORCL)



Today, Oracle Health Sciences announced the availability of with , the latest release in Oracle's e-clinical solutions suite. The solution provides trial sponsors and contract research organizations (CROs) with an integrated solution to efficiently design, conduct and manage EDC-based, global clinical trials.

Oracle Health Sciences InForm 6.0 with Oracle Health Sciences Central Designer 2.0 includes several new features that help streamline trial design, data collection management and review so customers can:

Accelerate data collection and improve site experience with interface enhancements to handle repeating data as well as new dynamic data entry displays

Simplify and automate data exchange utilizing the CDISC Operational Data Model (CDISC-ODM) standard to import data into InForm through a new Clinical API

Improve productivity by eliminating redundant source data verification with advanced targeted source verification enhancements

View, identify and manage study priorities and accelerate data cleaning with enhanced Data Viewer displays

Utilize mobile technology through support for iPad and Android devices

Increase flexibility for mid-study changes with advanced batch calculation rules options

New Central Designer enhancements further streamline the process for designing and building EDC studies with:

Dynamic prompts for faster electronic edit checks writing

Offline translation to speed the translation process for multi-language studies



"In today's global clinical research environment, the focus is on simultaneously improving clinical trial management and boosting clinical program productivity. The latest release of Oracle Health Sciences InForm and Oracle Health Sciences Central Designer address both these objectives, helping health sciences organizations to accelerate innovation and time to market," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Oracle Health Sciences InForm GTM with Oracle Health Sciences Central Designer help streamline study design and setup while improving the automation and efficiency of global EDC-based trials."

Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NASDAQ: ORCL), visit .

Oracle industry solutions leverage the company's best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.

At Oracle, we believe that a more predictive, preventive, personalized and participatory system will help improve human health. We can help accelerate this journey to personalized medicine through technology, data and insights. Oracle's solutions support industry initiatives to improve care quality and outcomes, reduce costs, and speed time to market for new treatments, therapies and devices. For more information, visit

Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.



Greg Lunsford
Oracle
+1.650.506.6523


Mary Tobin
O'Keeffe & Company
+1.503.658.7396

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 24.06.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 272404
Anzahl Zeichen: 0

contact information:
Town:

REDWOOD SHORES, CA

Kategorie:

Software

Diese Pressemitteilung wurde bisher 257 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Oracle Health Sciences InForm GTM 6.0 With Oracle Health Sciences Central Designer 2.0 Accelerates Clinical Studies"
steht unter der journalistisch-redaktionellen Verantwortung von

Oracle Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Oracle Statement ...

REDWOOD SHORES, CA -- (Marketwired) -- 06/30/16 --"Five years ago, Oracle made a software development announcement which accurately reflected the future of the Itanium microprocessor. Two trials have now demonstrated clearly that the Itanium chi ...

Oracle Cloud Improves Financial Process Visibility and Cuts Upgrade Costs for Un ...

REDWOOD SHORES, CA -- (Marketwired) -- 06/30/16 -- has paired its top-notch educational programs with the technology to advance them. With , KU will drive strategic student educational initiatives, focus on operational efficiencies and reduce costs ...

Oracle Prices $14 Billion Aggregate Principal Amount of Investment Grade Notes ...

REDWOOD SHORES, CA -- (Marketwired) -- 06/29/16 -- Oracle Corporation (NYSE: ORCL) announced the pricing of its sale of $4,250,000,000 of 1.900% Notes due 2021 (the "2021 Notes"), $2,500,000,000 of 2.400% Notes due 2023 (the "2023 Not ...

Alle Meldungen von Oracle Corporation